medigraphic.com
ISSN 1561-3038 (Print)

2018, Number 4

<< Back Next >>

Rev Cubana Med Gen Integr 2018; 34 (4)

Use fulness of the clinical method for diagnosing a group of clinical syndromes

Taboada LN, Lardoeyt FR

Language: Spanish
References: 30
Page: 121-141
PDF size: 323.03 Kb.


ABSTRACT

Introduction: The scientific method is a general method which consists of several stages necessary for the development of all scientific research. It is the way to approach reality and to study the phenomena of nature, to discover their essence and interrelations. The clinical method is the particular application of the scientific method in the medical practice, and in the current economic conditions prevailing worldwide, its application is of inestimable value because of the advantages it brings from that point of view, as well as for the well-being of the patient, who would not be subjected to unnecessary and expensive diagnostic procedures.
Objective: To propitiate the medical personnel with the clinical criteria to achieve, through the use of the clinical method, the diagnosis of some genetic syndromes. Such criteria have been elaborated after an exhaustive clinical description of those conditions.
Methods: A revision of basic books of clinical genetics and syndromology despite their year of publication and a research in data bases such as Medline, Lilacs and Cochrane in the period from 2012 to 2016.
Conclusions: The criteria established for the clinical diagnosis of fourteen genetic syndromes have been presented.


REFERENCES

  1. Cummings MR. A perspective on Human Genetics. In: Human Heredity. Principles and Issues. 8th ed. California: Cengage Learning; 2009.

  2. Vicente OEF, Almaguer DAJ, García RRE. Consideraciones de la enseñanza del método clínico en la formación médica superior. Educ Med Sup. 2015 [citado 23 Ene 2018];29(1):182-90. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21412015000100017

  3. Alfonso JA, Laucirica Hernández C, Mondejar Rodríguez J. El método clínico frente a las nuevas tecnologías. Rev Med Electron. 2014 [citado 23 Ene 2018];36(4):499-511. Disponible en: http://www.revmatanzas.sld.cu/revista %20medica/ano%202014/vol4%202014/tema12.htm

  4. Lyon Jones K. Smith´s recognizable patterns of human malformation. 6th ed. Philadelphia: Elsevier Saunders; 2006.

  5. Padilla Suárez E, Suárez Isaqui L, Troya Borges T, Martínez Abreu J. La evaluación médica en la atención primaria de salud. Rev Med Electron. 2014 [citado 23 Ene 2018];36(2):230-7. Disponible en: http://www.revmatanzas.sld.cu/revista %20medica/ano %202014/vol2 %202014/tema13.htm

  6. Moreno RMA. ¿Análisis Complementarios vs. Método Clínico? Rev Habanera Cienc Med. 2014 [citado 23 Ene 2018];13(5):650-6. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1729-519X2014000500001&script=sci_arttext&tlng=pt

  7. McKusick`s. On line Mendelian Inheritance in Man (OMIM). 2018 [citado 23 Ene 2018]. Disponible en: http://www.omim.org

  8. Ulrich NJ. Neurocutaneous syndromes and brain tumors. J Child Neurol. 2018 [citado 23 Ene 2018];31(12):1399-1411. Disponible en: http://journals.sagepub.com/doi/pdf/10.1177/0883073815604220

  9. Taboada Lugo N, Lardoeyt Ferrer R. Criterios para el diagnóstico clínico de algunos síndromes genéticos. Rev Cubana Pediatr. 2003 [citado 23 Ene 2018];75(1). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0034-75312003000100007&script=sci_arttext

  10. Lardoeyt Ferrer R, Taboada Lugo N, Vázquez SV, Marcheco Teruel B, Rojas BI, Herrera Martínez M, et al. Fundamentos de Genética Médica Poblacional. La Habana: Editorial de Ciencias Médicas. 2016 [citado 23 Ene 2018]. Disponible en: http://www.bvs.sld.cu/libros/fundamento_genetica/indice_p.htm

  11. Vargas Flores T, Rojas Mamani CM. Neurofibromatosis tipo 1. Rev Act Clin Med. 2014 [citado 23 Ene 2018];45:2400-5. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?script=sci_pdf&pid=S2304-37682014000600009&lng=es&nrm=iso&tlng=es

  12. Salas San Juan O, Brooks Rodríguez M, Acosta Elizastigui T. Síndromes Neurocutáneos identificables por el Médico General Integral mediante examen físico. Revista Cubana Med Gen Integral. 2013 [citado 23 Ene 2018];29(3):325-35. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252013000300010&lng=en&tlng=en

  13. Stafstrom CE, VStaedtke V, Comi AM. Epilepsy mechanisms in neurocutaneous disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome. Front Neurol. 2017 [citado 23 Ene 2018];8:87. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355446/

  14. Manara R, Bugin S, Pelizza MF, Sartori S, Nosadini M, Labriola F, et al. Genetic and imaging features of cerebellar abnormalities in tuberous sclerosis complex: more insights into their pathogenesis. Dev Med Child Neurol. 2018 [citado 23 Ene 2018];60(7):724-5. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/dmcn.13769

  15. Romero A, Salazar M, Tufino M, Villacís A, Galarza F. Hipomelanosis de Ito. Dermatol Rev Mex. 2015 [citado 23 Ene 2018];59(1):43-8. disponible en: http://www.med.unne.edu.ar/home/images/documentos/Revista_Numero/Hipomelanosis_Inf_breve_1.pdf

  16. Prudencio Beltrán R, López Loayza F, Flores Leque A, Siles Arias. Hipomelanosis de Ito. Arch.Boliv.Med. 2015 [citado 7 Mar 2018];23(91):69-74. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?script=sci_arttext&pid=S0004-05252015000200008&lng=es

  17. Moore KL, Persaud TVN. Embriología Clínica. 8ª ed. Barcelona: Elsevier España S.L; 2011.

  18. Nakashima M, Miyajima M, Sugano H, Limura Y, Kato M, Tsurusaki Y, et al. The somatic GNAQ mutation c.548G>A (p.R183Q) is consistently found in Sturge-Weber síndrome. J Human Genet. 2014 [citado 23 Ene 2018];59:691-3. Disponible en: https://www.nature.com/articles/jhg201495.pdf

  19. Sood D, Rathore A, Sood I, Kumar D, Sood NN. Long-term intraocular pressure after combined trabeculotomy-trabeculectomy in glaucoma associated with Sturge-Weber syndrome. Europ J Ophth. 2018 [citado 23 Ene 2018];28(2):210-5. Disponible en: http://journals.sagepub.com/doi/10.5301/ejo.5001024

  20. Seo GH, Kim YM, Kang E, Kim GH, Seo EJ, Lee BH, et al. The phenotypic heterogeneity of patients with Marfan-related disorders and their variant spectrums. Medicine. 2018 [citado 7 May 2018];97(20):1-6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976283/

  21. Wang Y, Li X, Li R, Yang Y, Du J. Identification of novel causal FBN1 mutations in pedigrees of Marfan Syndrome. Int J Genomics. 2018 [citado 7 May 2018]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932419/

  22. Mulle JG, Pulver AE, McGrath JA, Woyniec PS, Dodd AF, Cutler DJ et al. Reciprocal duplication of the Williams-Beuren Syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psych. 2014 [citado 23 Ene 2018];75(5):371-7. Disponible en: http://www.sciencedirect.com/science/article/pii/S0006322313005271

  23. Panduranga P, Rajarao MP. Williams Syndrome and right ventricular noncompaction: A rare association. J Cardiovasc Echogr. 2018 [citado 23 Ene 2018];28(1):69-71. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875143/

  24. Zucker EJ. Syndromes with aortic involvement: pictorial review. Cardiovasc Diagn Ther. 2018 [citado 23 Ene 2018];(Suppl 1):S71-S81. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949600/pdf/cdt-08-S1-S71.pdf

  25. Capelato RRC, Mechereffe DAD, Milanez MMA, Soriano EMP, Marques BA. Proteus síndrome. An Bras Dermatol. 2017 [citado 23 Ene 2018];92(5):717-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674710/pdf/abd-92-05-0717.pdf

  26. Sun M, Connizzo BK, Adams S, Frredman B, Wenstrup R, Soslowsky L et al. Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos Syndrome joint phenotype. Am J Pathol. 2015 [citado 23 Ene 2018];185(5):1436-47. Disponible en: http://www.sciencedirect.com/science/article/pii/S0002944015001303

  27. Malfait F, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, et al. The 2017 international classification on the Ehlers-Danlos syndromes. Am J Med Genet. 2017 [citado 23 Ene 2018];175C:148-57. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.c.31552

  28. Syx D, De Wandele I, Rombaut L, Malfait F. Hypermobility, the Ehlers-Danlos syndromes and chronic pain. Clin Exp Rheumatol. 2017 [citado 23 Ene 2018];35(Suppl 5):116-22. Disponible en: http://www.clinexprheumatol.org/article.asp?a=12284

  29. Retana GV, Segura AL. Síndrome de Noonan. Med Leg Costa. 2014 [citado 23 Ene 2018];175C31(1):129-33. Disponible en: http://www.scielo.sa.cr/scielo.php?pid=S1409-00152014000100014&script=sci_arttext&tlng=pt

  30. Khorgami MR, Moradian M, Omidi N, Aarabi Moghadam MY. Management of cardiovascular disorders in patients with Noonan Syndrome: A Case Report. J Tehran Heart Cent. 2017 [citado 23 Ene 2018];12(4):184-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849592/




2020     |     www.medigraphic.com